Related references
Note: Only part of the references are listed.High-temperature-required protein A2 as a predictive marker for response to chemotherapy and prognosis in patients with high-grade serous ovarian cancers
M. Miyamoto et al.
BRITISH JOURNAL OF CANCER (2015)
Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma
Bozena Dobrzycka et al.
TUMOR BIOLOGY (2015)
A dual role for Caspase8 and NF-kappa B interactions in regulating apoptosis and necroptosis of ovarian cancer, with correlation to patient survival
L. Hernandez et al.
CELL DEATH DISCOVERY (2015)
Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples
Markus Riester et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Association of expression of XIAP-associated factor 1 (XAF1) with clinicopathologic factors, overall survival, microvessel density and cisplatin-resistance in ovarian cancer
YunXia Wang et al.
REGULATORY PEPTIDES (2012)
The Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian Cancer
Gong Yang et al.
CLINICAL CANCER RESEARCH (2011)
Bim Protein Degradation Contributes to Cisplatin Resistance
Juan Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosis
Inigo Espinosa et al.
MODERN PATHOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Activation of NF-KB Signaling by Inhibitor of NF-KB Kinase β Increases Aggressiveness of Ovarian Cancer
Lidia Hernandez et al.
CANCER RESEARCH (2010)
Cleaved caspase-3 and nuclear factor-κB p65 are prognostic factors in metastatic serous ovarian carcinoma
Lilach Kleinberg et al.
HUMAN PATHOLOGY (2009)
Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells
Karin Simonin et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
Katy Milne et al.
PLOS ONE (2009)
Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome
Richard W. Tothill et al.
CLINICAL CANCER RESEARCH (2008)
Share Paper
